Cervical conization

Today, Cervical conization is a topic that generates great interest and debate in society. Its relevance has been increasing in recent years, covering various areas such as technology, culture, politics and science. Cervical conization has managed to capture the attention of experts and fans, as well as citizens in general, becoming a fundamental part of the media and social agenda. In this article, we will explore in depth the different aspects and facets related to Cervical conization, with the aim of offering a comprehensive and updated vision on this topic of great importance today.

Cervical conization
ICD-9-CM67.2

Cervical conization refers to an excision of a cone-shaped portion of tissue from the mucous membrane of the cervix. Conization is used for diagnostic purposes as part of a biopsy and for therapeutic purposes to remove pre-cancerous cells (cervical intraepithelial neoplasia) or early stage cervical cancer.[1]

Types

Types include:[2][3]

Side effects

Cervical conization effectively reduces the risk of cancer developing or spreading but it causes an increased risk of premature birth in future pregnancies.[2][3]

The chances of cancer recurrence and premature birth depends on the type of conization. Cold knife conization is associated with 7% chance of the cancer recurring and 16% chance of premature birth, laser conisation comes with 6% cancer recurrence and 13% premature birth, and loop excision comes with 10% recurrence and 11% premature birth.[2][3]

See also

References

  1. ^ Cooper, Danielle B.; Carugno, Jose; Menefee, Gary W. (2023), "Conization of Cervix", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 28722875, retrieved 2023-11-16
  2. ^ a b c Athanasiou, Antonios; Veroniki, Areti Angeliki; Efthimiou, Orestis; Kalliala, Ilkka; Naci, Huseyin; Bowden, Sarah; Paraskevaidi, Maria; Arbyn, Marc; Lyons, Deirdre; Martin-Hirsch, Pierre; Bennett, Phillip; Paraskevaidis, Evangelos; Salanti, Georgia; Kyrgiou, Maria (2022-07-25). "Comparative effectiveness and risk of preterm birth of local treatments for cervical intraepithelial neoplasia and stage IA1 cervical cancer: a systematic review and network meta-analysis". The Lancet Oncology. 23 (8): 1097–1108. doi:10.1016/S1470-2045(22)00334-5. PMC 9630146. PMID 35835138.
  3. ^ a b c "Prevention of cervical cancer: what are the risks and benefits of different treatments?". NIHR Evidence (Plain English summary). National Institute for Health and Care Research. 2023-11-10. doi:10.3310/nihrevidence_60599. S2CID 265201829.


Stub icon

This oncology article is a stub. You can help Wikipedia by expanding it.